gland pharma glp-1 capacity Shares Surge After Announcing Strong Q3FY26 Results GLP1: How Indian pharma giants

These are the same side effects you experienced during titration, just temporarily amplified

What our study suggests is something broader: GLP-1 drugs may also quiet what I call drug noise, the relentless craving that drives addiction across substances

however, the intracellular signalling mechanisms underlying these effects remain poorly defined

Research published in Frontiers in Immunology demonstrated that these patients show reduced microbial diversity, decreased populations of beneficial bacteria (including Lactobacillus and Bifidobacterium species), and increased intestinal permeability, commonly known as leaky gut

When GIPRAs and GLP-1RAs were co-administered to obese mice, the combination significantly enhanced both appetite suppression and weight loss compared to monotherapy [33, 34]

[DOI] [PMC free article] [PubMed] [Google Scholar] 455.Ast J, et al